Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-20-139783

Chief Financial Officer bought 7,407 shares at $1.35 ($9,999)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Elefant Dov Chief Financial Officer 2020-12-28 Purchase +7,407 $1.35 $9,999 11,755 D
Open-market purchases · 7,407 sh · avg $1.35 · $9,999
Loading xslF345X03/tm2039438d1_4.xml…